Related Articles
Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma
NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery
Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer
Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis